Risk of bacteraemia and mortality in patients with haematological malignancies

Clinical Microbiology and Infection

Volumn 12, Issue 3, 2006, Pages 217-223

  Norgaard M ^a,b,c   Larsson, H ^a   Pedersen, G ^a   Schonheyder H C ^a   Sorensen H T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c Aalborg Hospital Aarhus University Hospital ^*  (Denmark)

Author keywords

Bacteraemia; Haematological malignancies; Incidence; Mortality; Risk

Indexed keywords

ANTIBIOTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CANCER MORTALITY; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; FEMALE; FOLLOW UP; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYCOSIS; NEUTROPENIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK ASSESSMENT;

NEGIBACTERIA; POSIBACTERIA;

EID: 33644896262     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01298.x     Document Type: Article

References (32)

1. Winton EF, Langston AA. Update in acute leukemia 2003: A risk adapted approach to acute myeloblastic leukemia in adults. Semin Oncol 2004; 31 (suppl): 80-86.
2. Kipps TJ. Chronic lymphocytic leukemia. Curr Opin Hematol 2000; 7: 223-234.
3. Raemaekers J, Kluin-Nelemans H, Teodorovic I et al. The achievements of the EORTC Lymphoma Group. Eur J Cancer 2002; 38 (suppl): 107-113.
4. Yung L, Linch D. Hodgkin's lymphoma. Lancet 2003; 361: 943-951.
5. Adami HO, Hunter D, Trichopoulos D, eds. Textbook of cancer epidemiology. New York: Oxford University Press, 2002.
6. Hersh EM, Bodey GP, Nies BA, Freireich EJ. Causes of death in acute leukemia: A ten-year study of 414 patients from 1954-1963. JAMA 1965; 193: 105-109.
7. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328-340.
8. Viscoli C, Bruzzi P, Castagnola E et al. Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer 1994; 30: 430-437.
9. Elting LS, Rubenstein EB, Rolston KV, Bodey GP. Outcomes of bacteremia in patients with cancer and neutropenia: Observations from two decades of epidemiological and clinical trials. Clin Infect Dis 1997; 25: 247-259.
10. Gonzalez-Barca E, Fernandez-Sevilla A, Carratala J et al. Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia. Eur J Clin Microbiol Infect Dis 1999; 18: 539-544.
11. Cherif H, Kronvall G, Björkholm M, Kalin M. Bacteraemia in hospitalised patients with malignant blood disorders: A retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. Hematol J 2003; 4: 420-426.
12. Hovgaard D, Skinhøj P, Bangsborg J et al. Bacteremia and candidemia in hematological malignancies: Clinical findings. Scand J Infect Dis 1988; 20: 495-501.
13. Rintala E. Incidence and clinical significance of positive blood cultures in febrile episodes of patients with hematological malignancies. Scand J Infect Dis 1994; 26: 77-84.
14. Günther G, Björkholm M, Björklind A, Engervall P, Stiernstedt G. Septicemia in patients with hematological disorders and neutropenia. A retrospective study of causative agents and their resistance profile. Scand J Infect Dis 1991; 23: 589-598.
15. Pagano L, Tacconelli E, Tumbarello M et al. Bacteremia in patients with hematological malignancies. Analysis of risk factors, etiological agents and prognostic indicators. Haematologica 1997; 82: 415-419.
16. Johansson PJ, Sternby E, Ursing B. Septicemia in granulocytopenic patients: A shift in bacterial etiology. Scand J Infect Dis 1992; 24: 357-360.
17. Andersen TF, Madsen M, Jørgensen J, Mellemkjær L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263-268.
18. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry - history, content, quality and use. Dan Med Bull 1997; 44: 535-539.
19. Schønheyder HC, Højbjerg T. The impact of the first notification of positive blood cultures on antibiotic therapy: A one-year survey. APMIS 1995; 103: 37-44.
20. Prag J, Jensen J, Lebech K. Colorbact, a visually read blood culture system using darkening of haemoglobin in aerobic blood cultures as an early growth indicator, compared with Bactec 6A and 7A. APMIS 1991; 99: 1089-1095.
21. Schønheyder HC. Two thousand seven hundred and thirty nine episodes of bacteremia in the county of Northern Jutland 1996-1998. Presentation of a regional clinical database. Ugeskr Laeger 2000; 162: 2886-2891.
22. Leibovici L, Drucker M, Samra Z, Konisberger H, Pitlik SD. Prognostic significance of the neutrophil count in immunocompetent patients with bacteraemia. Q J Med 1995; 88: 181-189.
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-383.
24. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: A critical review of available methods. J Clin Epidemiol 2003; 56: 221-229.
25. Thomsen RW, Hundborg HH, Lervang HH et al. Diabetes and outcome of community-acquired pneumococcal bacteremia: A 10-year population-based cohort study. Diabetes Care 2004; 27: 70-76.
26. Klastersky J, Zinner SH, Calandra T et al. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: Lessons from four EORTC trials. Eur J Cancer Clin Oncol 1988; 24 (suppl): 35-45.
27. Schimpff SC, Gaya H, Klastersky J, Tattersall MH, Zinner SH. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group. J Infect Dis 1978; 137: 14-29.
28. EORTC International Antimicrobial Therapy Cooperative Group. Gram-positive bacteraemia in granulocytopenic cancer patients. Eur J Cancer 1990; 26: 569-574.
29. Nørgaard M, Skriver MV, Gregersen H et al. The data quality of haematological malignancy ICD-10 diagnoses in a population-based Hospital Discharge Registry. Eur J Cancer Prev 2005; 14: 201-206.
30. Leibovici L, Samra Z, Konigsberger H et al. Long-term survival following bacteremia or fungaemia. JAMA 1995; 274: 807-812.
31. Bates DW, Pruess KE, Lee TH. How bad are bacteremia and sepsis? Outcomes in a cohort with suspected bacteremia. Arch Intern Med 1995; 155: 593-598.
32. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol 2004; 57: 131-141.